title: Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults.
abstract: This practice parameter describes treatment with stimulant medication. It uses an evidence-based medicine approach derived from a detailed literature review and expert consultation. Stimulant medications in clinical use include methylphenidate, dextroamphetamine, mixed-salts amphetamine, and pemoline. It carries FDA indications for treatment of attention-deficit/hyperactivity disorder and narcolepsy.
authors.forename: Laurence L
authors.initials: LL
authors.lastname: Greenhill
authors.forename: Steven
authors.initials: S
authors.lastname: Pliszka
authors.forename: Mina K
authors.initials: MK
authors.lastname: Dulcan
authors.forename: William
authors.initials: W
authors.lastname: Bernet
authors.forename: Valerie
authors.initials: V
authors.lastname: Arnold
authors.forename: Joseph
authors.initials: J
authors.lastname: Beitchman
authors.forename: R Scott
authors.initials: RS
authors.lastname: Benson
authors.forename: Oscar
authors.initials: O
authors.lastname: Bukstein
authors.forename: Joan
authors.initials: J
authors.lastname: Kinlan
authors.forename: Jon
authors.initials: J
authors.lastname: McClellan
authors.forename: David
authors.initials: D
authors.lastname: Rue
authors.forename: Jon A
authors.initials: JA
authors.lastname: Shaw
authors.forename: Saundra
authors.initials: S
authors.lastname: Stock
mesh_terms: D000293:Adolescent; D000328:Adult; D000662:Amphetamines / Q000627:therapeutic use; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D001921:Brain / Q000187:drug effects*; D000697:Central Nervous System Stimulants / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D000075202:Contraindications; D016903:Drug Monitoring; D019317:Evidence-Based Medicine; D006801:Humans; D008774:Methylphenidate / Q000627:therapeutic use; D009290:Narcolepsy / Q000188:drug therapy; D010389:Pemoline / Q000627:therapeutic use; D011600:Psychopharmacology; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D014481:United States
chemical_list: D000662:Amphetamines; D000697:Central Nervous System Stimulants; D011619:Psychotropic Drugs; D008774:Methylphenidate; D010389:Pemoline